|
1
|
|
$113M
|
+$1.72M
|
+79,530
|
+2%
|
|
|
2
|
State Street
Boston,
Massachusetts
|
$61.6M
|
-$7.45M
|
-345,389
|
-11%
|
|
|
3
|
Fidelity Investments
Boston,
Massachusetts
|
$61.2M
|
-$514K
|
-23,830
|
-0.9%
|
|
|
4
|
Nantahala Capital Management
New Canaan,
Connecticut
|
$61.2M
|
-$4.35M
|
-201,690
|
-7%
|
|
|
5
|
PFM Health Sciences
San Francisco,
California
|
$52.2M
|
-$1.96M
|
-90,997
|
-4%
|
|
|
6
|
|
$39.6M
|
+$3.25M
|
+150,555
|
+9%
|
|
|
7
|
Point72 Asset Management
Stamford,
Connecticut
|
$37.9M
|
-$55.8M
|
-2,587,056
|
-61%
|
|
|
8
|
Vanguard Group
Malvern,
Pennsylvania
|
$32M
|
-$486K
|
-22,543
|
-2%
|
|
|
9
|
683 Capital Management
New York
|
$26M
|
-$4.93M
|
-228,600
|
-17%
|
|
|
10
|
|
$24.1M
|
+$1.63M
|
+75,429
|
+8%
|
|
|
11
|
MPM BioImpact
Boston,
Massachusetts
|
$21.3M
|
+$20.3M
|
+939,966
|
New
|
|
|
12
|
|
$17.5M
|
+$3.36M
|
+155,907
|
+25%
|
|
|
13
|
Millennium Management
New York
|
$17M
|
+$16.1M
|
+748,060
|
New
|
|
|
14
|
Macquarie Group
Sydney, NSW 2000,
Australia
|
$16M
|
-$7.42K
|
-344
|
-0%
|
|
|
15
|
|
$15.2M
|
-$1.34M
|
-62,055
|
-8%
|
|
|
16
|
Tekla Capital Management
Boston,
Massachusetts
|
$14.8M
|
+$2.82M
|
+130,753
|
+25%
|
|
|
17
|
International Biotechnology Trust
London,
United Kingdom
|
$14.3M
|
+$1.88M
|
+87,000
|
+16%
|
|
|
18
|
Adage Capital Partners
Boston,
Massachusetts
|
$14.3M
|
+$3.77M
|
+175,000
|
+38%
|
|
|
19
|
Aquilo Capital Management
San Francisco,
California
|
$14.2M
|
-$4.67M
|
-216,617
|
-26%
|
|
|
20
|
Integral Health Asset Management
New York
|
$12.5M
|
+$2.52M
|
+117,000
|
+27%
|
|
|
21
|
AllianceBernstein
Nashville,
Tennessee
|
$11.5M
|
+$3.92M
|
+181,791
|
+56%
|
|
|
22
|
Ameriprise
Minneapolis,
Minnesota
|
$10.3M
|
-$1.08M
|
-49,884
|
-10%
|
|
|
23
|
|
$9.89M
|
-$740K
|
-34,326
|
-7%
|
|
|
24
|
Geode Capital Management
Boston,
Massachusetts
|
$9.31M
|
+$311K
|
+14,405
|
+4%
|
|
|
25
|
Bank of New York Mellon
New York
|
$7.55M
|
-$3.84K
|
-178
|
-0.1%
|
|
